NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Access Midstream Partners (ACMP) upgraded at Citigroup to Buy from Neutral, Citigroup said. $35 price target. Improved drop down visibility and counterparty risk profile.A.H. Belo Corporation (AHC) upgraded to hold at TheStreet Ratings. Albemarle Corporation (ALB) rated new Equal-weight at Morgan Stanley. More upside potential in other chemical "Big Ideas." Arrow Electronics (ARW) downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. $41 price target. Estimates also cut, given lower expected near-term demand. BCSB Bankcorp (BCSB) downgraded to hold at TheStreet Ratings. Bloomin Brands (BLMN) rated new Neutral at Deutsche. $16 price target. Company will struggle to receive a higher multiple. BMC Software (BMC) upgraded at Think Equity to Buy from Hold, Think said. $50 price target. ESM business has bottomed. Broadcom (BRCM - Get Report) upgraded at RBC from Sector Perform to Outperform, RBC Capital said. $46 price target. Company has a solid product pipeline. Boston Scientific (BSX) downgraded at Leerink to Market Perform, Leerink Swann said. $6 price target. Company will struggle to grow in declining markets. Dover Corp (DOV) rated new Neutral at Citigroup. $64 price target. Still in transition with plenty of energy. Fairchild Semiconductor (FCS) downgraded at Miller Tabak from Buy to Neutral, Miller Tabak said. $16 price target. Company is leveraged to slower macro growth. Intel (INTC - Get Report) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. $24 price target. PC market faces near-term headwinds. Lamar Advertising (LAMR) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company also placed on the Conviction List. $42 price target. Expect value from a likely REIT conversion. Manhattan Associates (MANH) upgraded at Think to Buy from Hold, ThinkEquity said. $67 price target. Steady IT spending trends. Molina Healthcare (MOH) downgraded at Jefferies to Underperform from Hold, Jefferies said. $19 price target. Poor execution. Marathon Petroleum (MPC) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $65 price target.